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Abstract  
Introduction: Irritable bowel syndrome (IBS) is one of the most common disorders diagnosed by gastroenterologists and a common cause of 
general practice visits. Although this disease is not life threatening, patients with IBS seem to be seriously affected in their everyday life. The study 
was designed to explore the pattern of IBS in clinical practice and the impact on the quality of life. Methods: This is a case control descriptive 
study. 117 individuals were included in this study. Rome II criteria were used for the diagnosis of IBS. Impact of IBS on patient's quality of life was 
determined by irritable bowel syndrome quality of life (IBS-QOL) questionnaire. Results: Prevalence of IBS among the study sample was 34.2%. 
10% were IBS-Diarrhea, 37.5% were IBS-Constipation and 52.5% were alternators. There is statistical insignificant relationship between IBS (+) 
and age while it was a significant relation regarding gender (more common among women 80%). There is statistical significance relationship 
between IBS (+) on one hand and marital status and occupational status on the other hand. Patients with IBS had statistically significant lower 
scores for all IBS- QOL domains compared with the control group. Conclusion: IBS is a prevalent disorder that affects females more than males 
and it has significant impacts on work, lifestyle and social well-being.  
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Introduction 
 
Irritable bowel syndrome (IBS) is one of the most common disorders diagnosed by gastroenterologists and a common cause of general practice 
visits [1]. It is widespread in all societies and socio-economic groups [2]. It is a common health problem affecting a substantial proportion of the 
population. Prevalence estimates usually range from 12–30% with rates vary significantly between countries and depend on the diagnostic criteria 
used [3]. American College of Gastroenterology IBS Task Force defined IBS as abdominal pain or discomfort that occurs in association with altered 
bowel  habits  over  a  period  of  at  least  3  months  [4].  Altered  bowel  function,  with  the  predominant  bowel  symptom  determining  the  sub-
classification of IBS: IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), or IBS with alternating symptoms of constipation or diarrhea (IBS-A) 
[5]. Doctors generally rely on symptom-based criteria. At least three sets of diagnostic criteria have been developed, including the Manning, Rome 
I and Rome II criteria. The Rome I and II criteria are more refined than the Manning criteria [6]. The Rome III updated criteria were published in 
April 2006. The principle difference between Rome III guidelines as compared with the Rome II criteria lies in the less restrictive timeframe for 
symptoms. Whereas the Rome II criteria require symptoms to be present for at least 12 weeks (not necessarily consecutive) in the past 12 
months, the Rome III criteria require symptoms to originate for 6 months prior to diagnosis, and be currently active for 3 months [7]. Many IBS 
patients have psychological symptoms including depression, anxiety, tension, insomnia, frustration. The onset and course of IBS are strongly 
influenced by psychosocial factors. However, IBS-D and IBS-C were both associated only with high anxiety, but not depression, compared to the 
non-IBS control group [8]  
  
In assessing the impact of a chronic disease such as IBS on sense of wellbeing and daily functioning, patient-centered outcome data of Health 
Related Quality of Life (HRQOL) are essential. Previous studies of the impact of IBS on quality of life have either used generic health-related quality 
of life measurements, such as SF-36, or IBS-specific HRQOL instruments. Disease-specific measures are especially used in clinical trials, while 
generic HRQOL measures are designed to evaluate aspects that are applicable to a population and therefore can provide a basis for comparisons 
with data from the general population [2]. Although this disease is not life threatening, patients with IBS seem to be seriously affected in their 
everyday life [9]. They describe their HRQOL as similar to or worse than that of patients with more serious or life-threatening illnesses such as 
gastroesophageal reflux disease (GERD), asthma, and end-stage renal disease [10]. For these reasons, medical and regulatory Food and Drug 
Administration (FDA) recommend routine assessment of HRQOL of more severely affected patients [11]. In the United States, IBS also puts a 
heavy economic burden on patients, employers, and the healthcare system, resulting in more than $10 billion in direct costs (eg, from office visits, 
medications) and $20 billion in indirect costs (eg, through work absenteeism and reduced productivity) each year[12] .  
  
Despite increase awareness of functional bowel disease as the irritable bowel syndrome, there is no accurate information on the epidemiology of it 
in Egypt. However, the irritable bowel syndrome is believed to be very common.  
  
This study aims to improve quality of life of patients with irritable bowel syndrome with 2 objectives; to assess the prevalence and symptom 
patterns of irritable bowel syndrome and to assess the impact of irritable bowel syndrome on the quality of life.  
  
  
Methods 
 
The study was carried out at 24 October Family Health Center, which locate at an urban area in Suez governorate from January 2008 to August 
2009. Subjects were individuals fulfilling the inclusion criteria as both male & female gender aged 18 to 65 years. All visited the center for general 
medical  problems.  The  exclusion  criteria  included  previously  diagnosed  patients  with  Crohn´s  disease,  ulcerative  colitis,  Coeliac  disease, 
diverticulitis, and peptic ulcer. The sample size was calculated using EPI-INFO statistical program with help of the following information: expected 
frequency=20%, worst acceptable result = 30%, so the sample size = 106. If we expect a 10% drop-out rate, then the sample size =117.  
  
A validated questionnaire was used in collecting data through face to face interview for eligible patients. The questionnaire was divided into three 
parts: The first part was designed to investigate individuals´ socio-economic demographic data and patient characteristics as age, sex, marital 
status,  education,  occupation,  three  regular  meals  per  day,  fiber  consumption,  daily  tea  consumption,  daily  coffee  consumption,  daily  cola 
consumption, smoking, laxative use, previous abdominal operation, previous psychological stress , and relation to hemorrhoids [13]. The second 
part was Rome II criteria for the diagnosis IBS & supportive symptoms for more detailed symptom description. Patients were defined as having IBS 
with diarrhea (IBS-D) if they experienced one or more of the following: Looser/more watery stools than usual, the need to pass stools more often 
than usual (>3 times/day), or periods of urgency. Patients with  other bowel habit patterns were defined as having alternating IBS (IBS-A). 
Differentiation into these specific IBS subtypes was based only on the symptoms suffered by each respondent, without reference to a specific time 
frame [6].  
  
The third part was designed to  investigate the impact of irritable bowel syndrome on quality of life that was determined by irritable bowel 
syndrome quality  of life (IBS-QOL) questionnaire (34 items) [14]. We used (IBS-QOL) questionnaire to compare between patients with IBS, 
according to the Rome II criteria (cases), and those not meeting the Rome criteria (control). The individual responses to the 34 items were 
summed and averaged for a total score and then transformed to a 0-100 scale for ease of interpretation with higher scores indicating better IBS 
specific quality of life. Eight subscale scores for the IBS-QOL were: 1-Dysphoria, 2-Interference with Activity, 3-Body Image, 4-Health Worry, 5-
Food Avoidance, 6-Social Reaction, 7-Sexual concerns, 8-Relationships. Statistical analysis was performed by using the Epi- Info (EPI6) computer 
software statistical package.  
  
Ethical considerations  
  
Aim of the research was explained to the participants. Informed consent from the participants was taken before starting the interview. The study 
was approved by the ethics committee of faculty of medicine, Suez Canal University and has been performed in accordance with the ethical 
standards laid down in the 1964 Declaration of Helsinki.  Page number not for citation purposes  3 
Results 
 
Out of 117 individuals, 40 adults had IBS (34.2%). 52.5% of them had IBS-A, 37.5% had IBS-C and 10% had IBS-D. Table 1 Shows that the 
majority of IBS (+) 48.72% were in age group 40-49 years old and there was no statistically significant relationship between age and IBS (+) 
(P>0.05). The prevalence of IBS (+) was significantly higher in females 41.1% with statistical difference with males (P<0.05). IBS (+) were 
highest in widow group 80% with statistical significance relationship between IBS (+) and marital status (p<0.05). There was no statistical 
significant relationship between IBS (+) and educational status (P>0.05). IBS (+) was highest in house-wives group 51.5%, there was statistical 
significant relationship between IBS (+) and occupational status (P<0.05). Table 2 shows characteristics of respondents with and without IBS-type 
symptoms. There was no statistical significant relationship between IBS (+) and persons not eating three regular meals per day, subjects without 
fiber in their diet, daily tea, coffee or cola consumption, and smoking (P>0.05). There was a significant relationship between IBS and psychological 
stress  (p<0.05).  There was  no  significant  relationship  between  IBS  and  laxative  Use,  previous  abdominal  operation  or  hemorrhoid  presence 
(p>0.05).  
  
Table 3 shows the symptom patterns experienced at evaluation, such as the frequency of motions, Stool consistency and abdominal discomfort. 
Bowel movements < 3 times a week was 82.5% in IBS (+) patients, while in IBS (-) was 19.5%. Bowel movements > 3 times a day was 57.5% in 
IBS (+) patients while was 3.9% in IBS (-).Stool consistency, hard stool was 80% in IBS (+) while was 40.26% in IBS (-) and Loose stool was 
52.5% in IBS (+) while was 0% in IBS (-). Straining was 80% in IBS (+) while was 5.2% in IBS (-).Urgency was 55% in IBS (+).Incomplete bowel 
movement was 87.5% related to IBS (+).Passing mucus was 32.5% in IBS (+)while was 0% in IBS (-). Abdominal distension was 90% in IBS (+) 
while was 49.35% in IBS (-).  
  
Table 4 shows Patients with IBS had statistically significant lower scores for all IBS- QOL domains compared with the general population (P<0.01). 
The most affected domain was the Food Avoidance scale and the least affected domains those of Relationships, Sexual concerns and Social 
reaction. By the logistic regression, daily cola consumption was unfortunately affecting QOL positively. IBS, Previous psychological stress, hard 
stool, straining, passing mucus and abdominal distension were negativity affecting QOL.  
  
  
Discussion 
 
In  the  present  study,  IBS  prevalence  of  34.2%  was  found.  This  prevalence  is  different  from  other  studies.  A  Canadian  sample  reported  a 
prevalence of 13.5% using Rome I and 12.1% using Rome II Criteria [15]. In the US householder survey, 11% of those surveyed reported 
symptoms consistent with IBS [16]. In a large survey (>41 000 patients) recently conducted in eight European countries, overall prevalence of IBS 
was 9.6%, and ranged from 6.2 to 12% across countries [17]. Clearly, IBS prevalence can vary substantially depending on the diagnostic criteria 
employed and type of the study [18].  
  
Most IBS sufferers in this study had alternating symptoms of constipation and diarrhea. This finding is consistent with Hungin et al. that reported 
most  IBS  sufferers  (74%)  had  alternating  symptoms  of  constipation  and  diarrhea  as  defined  by  doctors  and  diagnostic  criteria  [19].  Other 
published data reported most IBS sufferers had diarrhea predominant symptoms (IBS-D), Smith et al. found that a prevalence rate of IBS-D is the 
most common symptoms followed by IBS-A [20].  
  
The current study revealed that there was no statistical significant difference between IBS+ and controls regarding age difference (p>0.05), but 
the IBS prevalence was higher in age group 40-49 years (48.72%). Hungin et al. found that prevalence rates were highest among those aged 25-
54 years [19]. Kay et al [21] and Karaman et al [13] found an inverse relationship between age and IBS prevalence, perhaps because individuals 
might ignore IBS-related symptoms as their organic diseases become more dominant with increased age. We found also the prevalence of IBS was 
significantly more common among women (41.1%) than men (20.6%). This finding is consistent with Hungin et al [19] and Andrews et al [22] 
that found the prevalence of IBS among women was approximately two times higher than that recorded for men in individuals diagnosed with IBS. 
Although, this finding is in contrast with Minnesota study demonstrated that the age-adjusted prevalence of IBS using the Rome II criteria was 
higher in men than in women [23]. Moreover, studies conducted in Asian countries, such as India [24] and Taiwan [25] have reported a higher 
male or equal gender prevalence of IBS. Cultural factors as well as study methodology may explain in part these gender differences. For example 
The Manning criteria have been reported to be more sensitive in diagnosing IBS in women than in men [26] and it has been suggested that the 
Rome criteria are less sensitive in men as well, possibly because men report fewer non-painful IBS symptoms than women [27]. In this study, the 
prevalence of IBS was highest in widow individuals (80%) this may be due to increasing responsibilities and stressors. Andrews et al. found 
prevalence was higher among unmarried individuals compared with married (7.7% vs. 5.9%) [22]. However, we can not detect any significant 
difference according to educational status, while there was a significant relation with occupational status. These findings are consistent with 
Karaman et al. that found IBS prevalence did not show any significant difference according to educational status but it was significant regarding 
the occupational distribution [13]. Food intolerance has been proposed as a potential cause of GI symptoms in some patients with IBS however 
this link is not well established. Although some patients associate onset of IBS symptoms with ingestion of particular foods identification of true 
food intolerance is challenging and elimination diets are typically time-consuming and difficult to implement [28]. The present study showed no 
significant association between IBS and eating regular meals per day, insufficient fiber in diet, daily tea and coffee consumption, cola intake or 
smoking. Karaman et al. observed that IBS prevalence was higher in individuals who did not eat regular meals and who had insufficient fiber in 
their diet. Also observed IBS prevalence increased as the daily consumption of cola increased, but did not find any relation between IBS and daily 
consumption of tea and coffee or with alcohol intake [13]. Laxative use was not common among our patient with IBS. Chronic laxative use usually 
exists in constipation- predominant patients [16]. Karaman et al. observed that laxative drug use was common among Patients with the most 
prevalent being constipation [13]. In the present study there was no significant correlation between IBS and previous abdominal operation. This 
finding is in contrast with finding by Hasler and Schoenfeld who reviewed the prevalence of abdominal and pelvic surgeries in IBS patients and 
reported an increased number of cholecystectomies, hysterectomies, appendectomies and other surgeries in IBS patients [29]. IBS are increased 
during  and  after  sensorial  tension  and  stress  periods  [30].  The  current  results  showed  a  significant  relation  between  IBS  and  previous Page number not for citation purposes  4 
psychological stress. Studies evaluating the role of acute stress have shown that stress can result in release of stress-related hormones that affect 
colonic  sensorimotor  function  (eg,  corticotropin-releasing  factor  (CRF)  and  inflammatory  mediators  (e.g.,  interleukin  (IL)-1),  leading  to 
inflammation and altering GI motility and sensation [31]. However, other studies have shown no difference in psychiatric morbidity between IBS 
patients that improved and those that did not improve after 6-9 months follow-up [32].  
  
Impact of IBS on quality of life: In a systematic review by Bijkerk et al, it was shown that the IBS-QOL is the best of the five IBS-specific QOL 
scores to establish changes in health-related QOL [33]. In the present study, patients with IBS had statistically significant lower scores for all IBS- 
QOL domains compared with the general population. With the lowest score of QOL that of the Food Avoidance scale (mean= 38.54, S.D. = 27.33) 
and the highest score of QOL those of Relationships (mean= 69.79, S.D. =20.30) and sexual concerns (mean= 67.50, S.D =25.76). When the 
sexual concerns were assessed in our patients, it should be taken into account that they may hesitate or avoid expression of such topics even if 
they have any sexual problems. Cross-cultural difference between the countries (e.g. race, food, belief, social milieu and health-care system) might 
affect some dimensions of perception for the health-related QOL in patients with IBS. Kanazawa et al. observed that the mean overall score of the 
IBS-QOL-J in the Japanese subjects with IBS was significantly lower than those of the general population with the most affected domains are food 
avoidance (55.3 vs. 43.4), health worry (73.1 vs. 59.2) [34]. Other two studies showed a higher mean overall score of the IBS-QOL. In USA it was 
63.2[14], while in Spain it was 75.5[35]. By logistic regression test, the daily cola consumption was unfortunately affecting QOL positively. IBS, 
Previous psychological stress, hard stool, straining, passing mucus and abdominal distention were negativity affecting QOL.  
  
  
Conclusion 
 
IBS is a bio-psychosocial disorder. Biological, social, and psychological components play a role in disease perception, symptom generation, and 
healthcare seeking. For a physician to be truly effective in approaching the patient with IBS, all of these factors need to be considered. The results 
of the current study are important for directing our attention towards improving the quality of life of IBS patients in addition to symptomatic 
treatment.  
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Table 3: Supportive symptoms of Irritable Bowel Syndrome in a group of primary health care center attendees, Suez governorate, Egypt 
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Table  1: Distribution of irritable bowel syndrome (IBS+) subjects according to different socio-demographic characteristics in 
primary health care center attendees, Suez governorate, Egypt 
  
Item 
IBS 
Total (N=117)  X
2  P 
+ (N=40)  - (N=77) 
N  %  N  %  N  %       
Age                      
  
  
5.73 
  
  
  
  
0.125 
  
18-29 years  14  28.57  35  71.43  49  41.88 
30-39  5  22.73  17  77.27  22  18.81 
40-49  19  48.72  20  51.28  39  33.33 
≥ 50  2  28.57  5  71.43  7  5.98 
Gender                          
Male  8  20.6  31  79.4  39  33.3    
4.8 
  
0.028*  Female  32  41.1  46  58.9  78  66.7 
Marital status                         
Single  8  20.6  31  79.4  39  33.33    
  
8.4 
  
  
  
0.014* 
Married  28  38.4  45  61.6  73  62.39 
Widow  4  80  1  20  5  4.28 
Divorced  0  0  0  0  0  0 
Educational status                         
Illiterate  0  0  2  100  2  1.72    
  
  
4.3 
  
  
  
0.2 
Write & read  3  33.3  6  66.7  9  7.69 
Moderate  27  41.5  38  58.5  65  55.55 
High  10  24.3  31  75.7  41  35.04 
Occupational status                          
Officers  12  31.5  26  68.5  38  32.48    
  
  
  
13.75 
  
  
  
  
0.017 
Workers  4  23.5  13  76.5  17  14.53 
Housewives  18  51.5  17  48.5  35  29.91 
Students  0  0  13  100  13  11.11 
Others  6  42.8  8  57.2  14  11.97 
N = number of cases            +: with IBS          -: without IBS        *: P<0.05 Page number not for citation purposes  8 
 
  
 
 
 
 
 
 
 
 
Table  2:  Characteristics  of  respondents  with  and  without  Irritable  Bowel  Syndrome  (IBS)-type  symptoms  in  primary  health  care  center 
attendees, Suez governorate, Egypt 
  
  
Item 
  
state 
IBS    
Total (N=117) 
   X² 
  
P 
  
+ (N=40)  - (N=77) 
N  %  N  %  N  % 
                             
Three regular meals / day 
  
Present  19  47.5  37  48.1  56  47.8 
0.0  0.95 
Absent  21  52.5  40  51.9  61  52.1 
                             
Daily fiber consumption 
Present  20  50  28  36.4  48  41.2  2.01 
  
  
0.15 
Absent  20  50  49  63.6  69  58.9 
                             
Daily tea consumption 
0 cups  1  2.5  6  7.8  7  5.98 
  
2.1 
  
0.34  1-2 cups  31  77.5  51  66.2  82  70.1 
3+ cups  8  20  20  25.9  28  23.9 
                             
Daily coffee consumption 
0 cups  20  50  47  61.1  67  57.2 
  
2.04 
  
0.36  1-2 cups  20  50  29  37.7  49  41.9 
3+ cups  0  0  1  1.2  1  0.85 
                             
Daily cola consumption 
0 cups  24  60  45  58.4  69  58.97 
  
0.87 
  
0.64  1-2 cups  15  37.5  27  34.1  42  35.9 
3+ cups  1  2.5  5  6.5  6  5.1 
                             
Smoking 
  
Present  6  15  12  15.6  18  15.4 
0.01 
0.93 
   Absent  34  85  65  84.4  99  84.6 
                             
Laxative Use 
  
Present  7  17.5  12  15.6  19  16.2  0.07 
  
0.79 
   Absent  33  82.5  65  84.4  98  83.8 
                             
Previous abdominal operation 
  
Present  12  30  19  24.7  31  26.5 
0.38  0.53 
Absent  28  70  58  75.3  86  73.5 
                             
Psychological stress 
Present  33  82.5  42  54.5  75  64.1 
8.86 
  
0.002 
   Absent  7  17.5  35  45.5  42  38.9 
                             
Hemorrhoids 
  
Present  13  32.5  15  19.5  28  23.9 
2.43  0.11 
Absent  27  67.5  62  50.5  89  76.1 
N = number of cases            +: with IBS          -: without IBS         Page number not for citation purposes  9 
  
 
 
 
 
 
 
 
Table  4:  Comparison  of  health-related  quality  of  life  (IBS-QOL)  between  respondents  with  and  without  Irritable  Bowel 
Syndrome in a group of primary health care center attendees, Suez governorate, Egypt 
  
Quality of life subscales Scores  IBS (+) N=40  IBS (-) N=77 
t-test  P-value 
Mean  SD  Mean  SD 
Dysphoria  49.45  26.63  89.33  15.38  8.743  <0.001* 
Interference with activity  48.66  25.17  85.81  15.42  8.538  <0.001* 
Body image  61.56  23.02  92.86  12.07  8.043  <0.001* 
Health Worry  53.13  28.48  91.34  15.62  7.894  <0.001* 
Food avoidance  38.54  27.33  81.60  21.69  8.651  <0.001* 
Social reaction  65.63  20.61  90.83  16.18  6.732  <0.001* 
Sexual concerns  67.50  25.76  93.67  12.60  6.060  <0.001* 
Relationships  69.79  20.30  92.86  13.16  6.511  <0.001* 
Total  56.78  19.08  89.79  12.99  9.821  <0.001* 
N = number of cases            +: with IBS          -: without IBS        *: P<0.05 
  
 
Table 3: Supportive symptoms of Irritable Bowel Syndrome in a group of primary health care center attendees, Suez governorate, Egypt 
  
Symptoms 
IBS 
Total (N=117)  X² 
  
P-value 
  
+ (N=40)  - (N=77) 
No  %  No  %  No  % 
Bowel  movements  < 3 times a week  33  82.5  15  19.5  48  41.02  42.84  <0.001* 
Bowel movements > 3 times  a day  23  57.5  3  3.9  26  22.22  43.39  <0.001* 
Hard stool  32  80  31  40.26  63  53.8  16.59  <0.004* 
Loose stool  21  52.5  0  0  21  17.9  48.85  <0.001* 
Straining  32  80  4  5.2  36  30.76  68.56  <0.001* 
Urgency  22  55  2  2.6  24  20.5  43.96  <0.001* 
Incomplete  bowel movement  35  87.5  2  2.6  37  31.6  87.01  <0.001* 
Passing  mucus  13  32.5  0  0  13  11.11  27.91  <0.001* 
Abdominal distention  36  90  38  49.35  74  63.24  18.55  <0.001* 
N = number of cases            +: with IBS          -: without IBS        *: P<0.05 